HeyJaredKarin McCay
- Indexed articles, last 90 days
- 19
- Latest publication
- Sep 23, 2026
- Outlet visibility, for Kbtx
- Top 500K sites
- Earliest in this view
- Jul 9, 2026
Latest articles
Lubbock patient is among the first in West Texas to receive non-invasive liver cancer treatment (opens the original)
Read excerpt
LUBBOCK, Texas (KCBD) - A Lubbock man diagnosed with liver cancer is now cancer-free thanks to an incisionless, non-invasive technology recently introduced to West Texas. Juan Cruz is the first patient in Lubbock to undergo histotripsy using the Edison System at University Medical Center. The cutting-edge treatment landed at UMC through its partnership with the Texas Tech University Health Sciences Center’s Rural Cancer Collaborative. Approved by the FDA in 2023, histotripsy destroys liver cance
Lubbock patient is among the first in West Texas to receive non-invasive liver cancer treatment (opens the original)
Read excerpt
LUBBOCK, Texas (KCBD) - A Lubbock man diagnosed with liver cancer is now cancer-free thanks to an incisionless, non-invasive technology recently introduced to West Texas. Juan Cruz is the first patient in Lubbock to undergo histotripsy using the Edison System at University Medical Center. The cutting-edge treatment landed at UMC through its partnership with the Texas Tech University Health Sciences Center’s Rural Cancer Collaborative. Approved by the FDA in 2023, histotripsy destroys liver cance
Lubbock patient is among the first in West Texas to receive non-invasive liver cancer treatment (opens the original)
Read excerpt
LUBBOCK, Texas (KCBD) - A Lubbock man diagnosed with liver cancer is now cancer-free thanks to an incisionless, non-invasive technology recently introduced to West Texas. Juan Cruz is the first patient in Lubbock to undergo histotripsy using the Edison System at University Medical Center. The cutting-edge treatment landed at UMC through its partnership with the Texas Tech University Health Sciences Center’s Rural Cancer Collaborative. Approved by the FDA in 2023, histotripsy destroys liver cance
TTUHSC prof retires after nearly 50 years of accomplishments (opens the original)
Read excerpt
LUBBOCK, Texas (KCBD) - Dr. Samuel Prien, a professor of reproductive physiology and obstetrics and gynecology at the Texas Tech University Health Sciences Center School of Medicine, is retiring at the end of this month after nearly 50 years. Prien has taught at least 10,000 students over the years. “I know we averaged for quite a while 100 babies a year,” Prien said. The first successful birth through assisted reproductive technology, or ART, at the Texas Tech Health Sciences Center occurred in
TTUHSC prof retires after nearly 50 years of accomplishments (opens the original)
Read excerpt
LUBBOCK, Texas (KCBD) - Dr. Samuel Prien, a professor of reproductive physiology and obstetrics and gynecology at the Texas Tech University Health Sciences Center School of Medicine, is retiring at the end of this month after nearly 50 years. Prien has taught at least 10,000 students over the years. “I know we averaged for quite a while 100 babies a year,” Prien said. The first successful birth through assisted reproductive technology, or ART, at the Texas Tech Health Sciences Center occurred in
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 500K sites
For Kbtx, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.